{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T19:10:07Z","timestamp":1793214607386,"version":"4.5.0"},"reference-count":26,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2009,10,1]],"date-time":"2009-10-01T00:00:00Z","timestamp":1254355200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,10,1]],"date-time":"2009-10-01T00:00:00Z","timestamp":1254355200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajo.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Ophthalmology"],"published-print":{"date-parts":[[2009,10]]},"DOI":"10.1016\/j.ajo.2009.05.008","type":"journal-article","created":{"date-parts":[[2009,7,2]],"date-time":"2009-07-02T04:58:13Z","timestamp":1246510693000},"page":"500-509.e2","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":214,"title":["Azathioprine for Ocular Inflammatory Diseases"],"prefix":"10.1016","volume":"148","author":[{"given":"Sirichai","family":"Pasadhika","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John H.","family":"Kempen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig W.","family":"Newcomb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa L.","family":"Liesegang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siddharth S.","family":"Pujari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James T.","family":"Rosenbaum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer E.","family":"Thorne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. Stephen","family":"Foster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas A.","family":"Jabs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grace A.","family":"Levy-Clarke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert B.","family":"Nussenblatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric B.","family":"Suhler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajo.2009.05.008_bib1","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/S0002-9394(00)00659-0","article-title":"Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panel","volume":"130","author":"Jabs","year":"2000","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajo.2009.05.008_bib2","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/0002-9343(88)90361-0","article-title":"Role of disease-modifying antirheumatic drugs versus cytotoxic agents in the therapy of rheumatoid arthritis","volume":"85","author":"Ward","year":"1988","journal-title":"Am J Med"},{"key":"10.1016\/j.ajo.2009.05.008_bib3","doi-asserted-by":"crossref","first-page":"2S","DOI":"10.1016\/S0041-1345(99)00840-4","article-title":"Choice of immunosuppressive drugs and individualization of immunosuppressive therapy for kidney transplant patients","volume":"31","author":"Danovitch","year":"1999","journal-title":"Transplant Proc"},{"key":"10.1016\/j.ajo.2009.05.008_bib4","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1111\/j.1529-8019.2007.00134.x","article-title":"Azathioprine: a guide for the management of dermatology patients","volume":"20","author":"Wise","year":"2007","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.ajo.2009.05.008_bib5","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1111\/j.1365-2036.2008.03732.x","article-title":"Comparative effectiveness of azathioprine in Crohn's disease and ulcerative colitis: prospective, long-term, follow-up study of 394 patients","volume":"28","author":"Gisbert","year":"2008","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.ajo.2009.05.008_bib6","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1097\/00124743-200106000-00005","article-title":"The long-term use of azathioprine in patients with psoriatic arthritis","volume":"7","author":"Lee","year":"2001","journal-title":"J Clin Rheumatol"},{"key":"10.1016\/j.ajo.2009.05.008_bib7","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1191\/096120301676669495","article-title":"Azathioprine therapy for patients with systemic lupus erythematosus","volume":"10","author":"Abu-Shakra","year":"2001","journal-title":"Lupus"},{"key":"10.1016\/j.ajo.2009.05.008_bib8","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/0002-9394(67)92517-2","article-title":"Effect of azathioprine (Imuran) on corneal graft reaction","volume":"64","author":"Polack","year":"1967","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajo.2009.05.008_bib9","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1136\/bjo.53.5.327","article-title":"Azathioprine in active chronic iridocyclitis","volume":"53","author":"Mathews","year":"1969","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ajo.2009.05.008_bib10","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1038\/eye.1998.203","article-title":"The role of azathioprine in the management of retinal vasculitis","volume":"12","author":"Greenwood","year":"1998","journal-title":"Eye"},{"key":"10.1016\/j.ajo.2009.05.008_bib11","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1056\/NEJM199002013220501","article-title":"A controlled trial of azathioprine in Beh\u00e7et's syndrome","volume":"322","author":"Yazici","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ajo.2009.05.008_bib12","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1002\/art.1780400425","article-title":"Azathioprine in Beh\u00e7et's syndrome: effects on long-term prognosis","volume":"40","author":"Hamuryudan","year":"1997","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ajo.2009.05.008_bib13","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1136\/bjo.52.9.688","article-title":"Sympathetic ophthalmitis treated with azathioprine","volume":"52","author":"Moore","year":"1968","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ajo.2009.05.008_bib14","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1016\/S0161-6420(91)32198-5","article-title":"Triple agent immunosuppression in serpiginous choroiditis","volume":"98","author":"Hooper","year":"1991","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2009.05.008_bib15","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1080\/09286580701585892","article-title":"Methods for identifying long-term adverse effects of treatment in patients with eye diseases: the Systemic Immunosuppressive Therapy for Eye Diseases (SITE) Cohort Study","volume":"15","author":"Kempen","year":"2008","journal-title":"Ophthalmic Epidemiol"},{"key":"10.1016\/j.ajo.2009.05.008_bib16","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.ajo.2005.03.057","article-title":"Standardization of uveitis nomenclature for reporting clinical data","volume":"140","author":"Jabs","year":"2005","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajo.2009.05.008_bib17","series-title":"Analysis of Survival Data","author":"Cox","year":"1984"},{"key":"10.1016\/j.ajo.2009.05.008_bib18","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1080\/01621459.1989.10478874","article-title":"The robust inference for the Cox proportional hazards model","volume":"84","author":"Lin","year":"1989","journal-title":"J Am Stat Assoc"},{"key":"10.1016\/j.ajo.2009.05.008_bib19","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1016\/j.ophtha.2008.04.026","article-title":"Comparison of antimetabolite drugs as corticosteroid-sparing therapy for noninfectious ocular inflammation","volume":"115","author":"Galor","year":"2008","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2009.05.008_bib20","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1001\/archopht.1978.03910050115002","article-title":"Immunosuppressive therapy for severe chronic uveitis","volume":"96","author":"Andrasch","year":"1978","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ajo.2009.05.008_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.ophtha.2009.04.020","article-title":"Methotrexate for ocular inflammatory diseases","author":"Gangaputra","year":"2009","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajo.2009.05.008_bib22","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/0002-9343(88)90079-4","article-title":"Azathioprine hypersensitivity","volume":"84","author":"Saway","year":"1988","journal-title":"Am J Med"},{"key":"10.1016\/j.ajo.2009.05.008_bib23","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.ajo.2008.04.035","article-title":"Long-term risk of malignancy among patients treated with immunosuppressive agents for ocular inflammation: a critical assessment of the evidence","volume":"146","author":"Kempen","year":"2008","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajo.2009.05.008_bib24","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.b2480","article-title":"Risk of overall and cancer mortality among patients with ocular inflammation treated with immunosuppressive therapy: retrospective cohort study","author":"Kempen","year":"2009","journal-title":"Br Med J"},{"key":"10.1016\/j.ajo.2009.05.008_bib25","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1002\/bdra.20399","article-title":"Pregnancy outcome of women exposed to azathioprine during pregnancy","volume":"79","author":"Goldstein","year":"2007","journal-title":"Birth Defects Res A Clin Mol Teratol"},{"key":"10.1016\/j.ajo.2009.05.008_bib26","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/0016-5085(90)91027-4","article-title":"Safety of azathioprine in pregnancy in inflammatory bowel disease","volume":"99","author":"Alstead","year":"1990","journal-title":"Gastroenterology"}],"container-title":["American Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939409003456?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939409003456?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T12:59:53Z","timestamp":1757595593000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002939409003456"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,10]]},"references-count":26,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2009,10]]}},"alternative-id":["S0002939409003456"],"URL":"https:\/\/doi.org\/10.1016\/j.ajo.2009.05.008","relation":{},"ISSN":["0002-9394"],"issn-type":[{"value":"0002-9394","type":"print"}],"subject":[],"published":{"date-parts":[[2009,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Azathioprine for Ocular Inflammatory Diseases","name":"articletitle","label":"Article Title"},{"value":"American Journal of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajo.2009.05.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}